| Gregory Bedynek, DO | |
|
2710 Saint Francis Dr Ste 110, Waterloo, IA 50702-5664 | |
| (319) 272-5000 | |
| (319) 272-6775 |
| Full Name | Gregory Bedynek |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 30 Years |
| Location | 2710 Saint Francis Dr Ste 110, Waterloo, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831129634 | NPI | - | NPPES |
| 204446900 | Medicaid | MO | |
| 200369700A | Medicaid | KS | |
| P00317215 | Other | MO | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 2005034466 (Missouri) | Secondary |
| 207T00000X | Neurological Surgery | DO-05563 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Waterloo Medical Center | Waterloo, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Center Inc | 0244148732 | 211 |
News Archive
A new study published in Open Access journal PLOS Biology by the Global Biological Standards Institute (GBSI) and two leading economists estimates that, in the U.S. alone, approximately $28 billion per year is spent on preclinical research that is not reproducible.
Aging-related tissue degeneration can be caused by mitochondrial dysfunction in tissue stem cells. The research group of Professor Anu Suomalainen Wartiovaara at the University of Helsinki, with their collaborators in Max Planck Institute for Biology of Aging, Karolinska Institutet and University of Wisconsin, reported on the 3rd January in Cell Metabolism their results on mechanisms of aging-associated degeneration.
"This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna.
Isotechnika Pharma Inc. today announced that their partner, Lux Biosciences, Inc., has received a Complete Response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding their New Drug Application (NDA) for voclosporin. Lux's NDA, filed in February 2010, seeks approval for voclosporin in the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye.
Researchers at the University of Health Sciences, Medical Informatics and Technology and the University of the Balearic Islands have confirmed the analgesic effects of social support - even without verbal or physical contact.
› Verified 8 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548288160 PECOS PAC ID: 0244148732 Enrollment ID: O20031111000534 |
News Archive
A new study published in Open Access journal PLOS Biology by the Global Biological Standards Institute (GBSI) and two leading economists estimates that, in the U.S. alone, approximately $28 billion per year is spent on preclinical research that is not reproducible.
Aging-related tissue degeneration can be caused by mitochondrial dysfunction in tissue stem cells. The research group of Professor Anu Suomalainen Wartiovaara at the University of Helsinki, with their collaborators in Max Planck Institute for Biology of Aging, Karolinska Institutet and University of Wisconsin, reported on the 3rd January in Cell Metabolism their results on mechanisms of aging-associated degeneration.
"This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna.
Isotechnika Pharma Inc. today announced that their partner, Lux Biosciences, Inc., has received a Complete Response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding their New Drug Application (NDA) for voclosporin. Lux's NDA, filed in February 2010, seeks approval for voclosporin in the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye.
Researchers at the University of Health Sciences, Medical Informatics and Technology and the University of the Balearic Islands have confirmed the analgesic effects of social support - even without verbal or physical contact.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Bedynek, DO 2710 Saint Francis Dr Ste 110, Waterloo, IA 50702-5664 Ph: (319) 272-5000 | Gregory Bedynek, DO 2710 Saint Francis Dr Ste 110, Waterloo, IA 50702-5664 Ph: (319) 272-5000 |
News Archive
A new study published in Open Access journal PLOS Biology by the Global Biological Standards Institute (GBSI) and two leading economists estimates that, in the U.S. alone, approximately $28 billion per year is spent on preclinical research that is not reproducible.
Aging-related tissue degeneration can be caused by mitochondrial dysfunction in tissue stem cells. The research group of Professor Anu Suomalainen Wartiovaara at the University of Helsinki, with their collaborators in Max Planck Institute for Biology of Aging, Karolinska Institutet and University of Wisconsin, reported on the 3rd January in Cell Metabolism their results on mechanisms of aging-associated degeneration.
"This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna.
Isotechnika Pharma Inc. today announced that their partner, Lux Biosciences, Inc., has received a Complete Response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding their New Drug Application (NDA) for voclosporin. Lux's NDA, filed in February 2010, seeks approval for voclosporin in the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye.
Researchers at the University of Health Sciences, Medical Informatics and Technology and the University of the Balearic Islands have confirmed the analgesic effects of social support - even without verbal or physical contact.
› Verified 8 days ago
Dr. Marietta Elizabeth Walsh, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2710 Saint Francis Dr, Suite 110, Waterloo, IA 50702 Phone: 319-272-5000 Fax: 319-272-6775 | |
Dr. Russell I. Buchanan, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2413 W Ridgeway Ave, Waterloo, IA 50701 Phone: 319-226-9888 Fax: 319-226-9889 | |
Dr. Hosung Chung, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1762 Caras Rd, Waterloo, IA 50701 Phone: 319-233-9567 Fax: 319-233-3061 |